Marking process of antineoplu00e1sticos with radionuclu00ecdeos; regagente for in vivo diagnosis and / or in vito the basis of antineoplu00e1sticos associated with radionuclu00ecdeos; in-vitro diagnostic methods and / or in vivo malignancy

摘要

Marking process of antineoplastic agents with radionuclu00ecdeos; reagent for diagnosis "in vivo" and / or in vitro the basis of antineoplastic agents associated with radionuclu00ecdeos; methods for the in vitro diagnostics and / or "in vivo" of neoplasms using the reagent thus obtained and kit for diagnosis of The base of the reagent and malignancies.The present invention relates to a process for marking an antineoplastic with radionuclides, as well as the reagent for diagnosis in vivo or in vitro the basis of an antineoplastic labeled with radionuclide, to their use for the diagnosis, the diagnostic method in vitro and in VI VO "of neoplasms and kit for diagnosis of cancers.The invention relates to the areas of medical and veterinary, aiming at the evaluation of malignancies such as acute leukemia, cancers (breast, broncogu00e9nico, thyroid and ovary), Wilms tumor, neuroblastoma, bone and soft tissue sarcomas, lymphomas (type Hodgkin s lymphoma Non Hodgkin lymphoma), and hepatomas and gastric tumors.In addition, shall also be indicated in the evaluation of the primary treatment of non metastatic carcinoma of the bladder (TIS, T1, T2).